YouTube content creation often feels like a guessing game, but a new strategy empowers creators to use ChatGPT for data-driven success. The AI transforms instinct into evidence by analyzing competitor ...

[!INCLUDE SQL Server] This topic describes how to manage partitions for a merge publication with parameterized filters in [!INCLUDE ssnoversion] by using [!INCLUDE ssManStudioFull], [!INCLUDE tsql], ...

Database Level TDE CMK is available for Azure SQL Database (all SQL Database editions). It is not available for Azure SQL Managed Instance, SQL Server on-premises, Azure VMs, and Azure Synapse ...

EXCLUSIVE: Veteran literary scout Philippa Donovan wants to reverse engineer the books-to-screen market through her new business, Two Script Studio. The operation will create ‘reverse adaptations‘ to ...

In this post, we will show you how to create email templates in the new Outlook app for Windows 11. Creating email or message templates in Microsoft Outlook (classic) involved manually composing an ...

The app, which allows casts and crews to mark up and revise scripts digitally, has diverted more than 120 million sheets from production sets worldwide over the past three years. By Kirsten Chuba ...

Office Scripts in Excel Online provide a practical way to automate repetitive tasks and streamline workflows. By using TypeScript and the Excel Document Object Model (DOM), users can programmatically ...

Feb 27 (Reuters) - Flagship-backed Generate Biomedicines' shares fell more than 6% in their Nasdaq debut on Friday, giving the drug developer a valuation of $1.91 billion, as lingering market ...

Generate:Biomedicines has earmarked $300 million of its IPO funds to complete a pair of phase 3 asthma trials for its anti-TSLP antibody GB-0895. (Fabrice Cabaud/Stock/Getty Images Plus) ...

Generate Biomedicines Inc., a biotechnology firm using artificial intelligence in drug development, is seeking to raise as much as $425 millon in an initial public offering, as listing activity in the ...

Generate Biomedicines, Inc. (GENB) has filed to raise public capital in an IPO to advance its pipeline of treatment candidates, according to an SEC filing. The company is developing treatments for ...